Definition
Components
-
Data Element ConceptCancer treatment—immunotherapy completion date
-
Object ClassCancer treatment
-
PropertyImmunotherapy completion date
-
-
Value DomainDate DDMMYYYY
Representation
This representation is based on the value domain for this data element, more information is available at " Date DDMMYYYY ".Data Type | Date/Time |
---|---|
Format | DDMMYYYY |
Maximum character length | 8 |
Comments
Guide for use:
The completion date of immunotherapy treatment is the date of the last dose administered during the course of treatment.
The completion date of immunotherapy treatment is recorded regardless of whether the course of treatment is completed as intended, and regardless of the intent or timing of the immunotherapy.
A patient may undergo immunotherapy for an extended period of time.
The completion date of the immunotherapy treatment is recorded even if the agent is experimental.
Multiple entries are not permitted.
Dates of surgical, radiotherapy and other systemic treatments are collected as separate items. However, if a patient receives treatment with a protocol that includes different types of systemic therapy agents, for example, a chemotherapy agent and an immunotherapy agent, record the completion date of treatment in both relevant data items.Origin:
Commission on Cancer, American College of Surgeons
Comments:
Collecting the start and finish dates for treatment modalities will enable an estimate of treatment duration.
References
American College of Surgeons 2002. Facility Oncology Registry Data Standards (FORDS), 2009 revision. Commission on Cancer
American College of Surgeons 1998. Standards of the Commission on Cancer: Registry Operations and Data Standards (ROADS), Volume II. Commission on Cancer
Johnson CH & Adamo M (Editors) 2007. SEER Program Coding and Staging Manual 2007, MD 2008 revision. Bethesda:National Cancer Institute, NIH Publication number 07-5581
This content Based on Australian Institute of Health and Welfare material. Attribution provided as required under the AIHW CC-BY licence.